| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
CAMBRIDGE, Mass.—Protein labeling has become an invaluable tool in understanding cell function, but the high-MW labels like GFP can perturb protein function while chemical modification methods lack the specificity of genetic tagging methods. Researchers at the Whitehead Institute of Biomedical Research recently tried to take the middle ground, using a chemoenzymatic labeling method the call sortagging.
 
As they describe in Nature Chemical Biology, sortagging relies on bacterial sortases, enzymes that covalently attach proteins to the bacterial cell wall via specific amino acid consensus sequences. Using S. aureus sortase A, which recognizes the LPXTG motif, the researchers were able to tag isolated soluble mouse MHC molecule genetically modified to carry the sequence LPETG near its C-terminus. They also found they could tag sequence-modified human CD154 proteins in both transfected-cell lysates and live cells, without labeling endogenous unmodified CD154 proteins.
 
"The multiplicity of sortases and their distinct recognition sequences, in principle, immediately expands the range of labeling possibilities to the simultaneous use of several uniquely tagged proteins and various probes in a single experimental setting," the authors write.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue